Viewing StudyNCT04381130



Ignite Creation Date: 2024-05-06 @ 2:38 PM
Last Modification Date: 2024-10-26 @ 1:34 PM
Study NCT ID: NCT04381130
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-20
First Post: 2020-05-07

Brief Title: A Phase IIIa Study of EF-009 in Patients With Pancreatic Cancer
Sponsor: Everfront Biotech Co Ltd
Organization: Everfront Biotech Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-09-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-01
Completion Date Type: ESTIMATED
First Submit Date: 2020-05-07
First Submit QC Date: May 7 2020
Study First Post Date: 2020-05-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-15
Last Update Post Date: 2024-02-20
Last Update Post Date Type: ACTUAL